Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding/operating status notice as well as the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedA government funding notice banner was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check65 days agoChange DetectedUI changes include showing the glossary, adding labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision tag to v3.4.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.3.4 was introduced; there are no visible user-facing changes to the Study Details page beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.